Miller School of Medicine >> UM Innovation >> Technology Transfer >> For Industry
 
Emergency Medicine
ID# UMF-29
More Details
Contact
Technology Peptides that enhance acetylcholinesterase expression
Scientific Relevance This invention uses peptides based on the amino terminal domain of the acetylcholinesterase (AChe) subunits ColQ and PRiMA together with an endoplasmic reticulum localization signal. When these peptides are administered to tissue cultured cells the expression of AChe is enhanced several fold potentially neutralizing the toxic effect of nerve gas and pesticide poisoning.
Commercial Opportunity There are close to 2 million acute pesticide poisonings reported per year with over 50,000 resulting in deaths.  Furthermore, the risk of terrorist poisoning is increasing continually.   An injectable peptide that can increase endogenous AChe levels is a potential therapy for nerve agent exposure of both military and civilian populations that has far reaching commercial and societal importance.
Competitive Advantage This is the only method that neutralizes toxic effects of nerve gas and pesticides by increasing levels of a naturally occurring enzyme. Furthermore, this is the only approach that can be used preventively, thus increasing the chance of survival of first responders.
Inventors Richard L. Rotundo and Carlos A. Ruiz
 
 
 

Copyright © 1997-2008
University of Miami,
All Rights Reserved.

Terms of Use
Privacy Statement
Contact Us
Medical Disclaimer
Site Map
Web Technology